REVOLUTION BIOMANUFACTURING INC

Capabilities

Revolution Biomanufacturing Inc. (RBIx ) is a U.S.-based biotechnology company pioneering rapid, scalable, and GMP-ready production of mRNA therapeutics and lipid nanoparticle (LNP) formulations to power the next generation of personalized medicines. As a 100% American-owned, woman-owned, and service-disabled veteran-owned enterprise, we are uniquely positioned to advance national health security and U.S. biotechnology independence. Our proprietary RevSelect platform combines AI-driven UTR optimization with tunable nano-delivery systems to achieve precise, tissue-specific mRNA expression across a broad range of therapeutic applications. By offering end-to-end support, from discovery through IND submission and clinical manufacturing. Revolution enables sponsors to accelerate timelines, de-risk development, and scale with regulatory confidence in gene and RNA-based therapeutics.